New clinical and molecular insights into Silver-Russell syndrome

Current Opinion in Pediatrics

Volumn 28, Issue 4, 2016, Pages 529-535

  Giabicani, Eloïse ^a,b,c   Netchine, Irène ^a,b,c   Brioude, Frédéric ^a,b,c  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

fetal growth; IGF2; imprinting disorders; Silver Russell syndrome

Indexed keywords

RECOMBINANT GROWTH HORMONE; SOMATOMEDIN B; IGF2 PROTEIN, HUMAN;

ADULTHOOD; CHROMOSOME 7; COPY NUMBER VARIATION; DEVELOPMENTAL DISORDER; DIET THERAPY; GENE DELETION; GENETIC COUNSELING; GENOTYPE; HUMAN; MAXILLOFACIAL DISORDER; MOLECULAR DIAGNOSIS; MOLECULAR PATHOLOGY; PHENOTYPE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SILVER RUSSELL SYNDROME; SMALL FOR DATE INFANT; UNIPARENTAL DISOMY; DNA METHYLATION; GENETICS; GENOME IMPRINTING; MULTIPLE MALFORMATION SYNDROME; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROCEDURES;

ABNORMALITIES, MULTIPLE; DNA METHYLATION; GENETIC COUNSELING; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; PHENOTYPE; PRACTICE GUIDELINES AS TOPIC; SILVER-RUSSELL SYNDROME;

EID: 84978634475     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000379     Document Type: Review

References (43)

1. Silver HK, Kiyasu W, George J, Deamer WC. Syndrome of congenital hemihypertrophy, shortness of stature, and elevated urinary gonadotropins. Pediatrics 1953; 12:368-376
2. Russell A. A syndrome of intra-uterine dwarfism recognizable at birth with cranio-facial dysostosis, disproportionately short arms, and other anomalies (5 examples). Proc R Soc Med 1954; 47:1040-1044
3. Black J. Low birth weight dwarfism. Arch Dis Child 1961; 36:633-644
4. DeChiara TM, Efstratiadis A, Robertsen EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990; 345:78-80
5. DeChiara TM, Robertson EJ, Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 1991; 64:849-859
6. Azzi S, Abi Habib W, Netchine I. Beckwith-Wiedemann and Russell-Silver Syndromes: from new molecular insights to the comprehension of imprinting regulation. Curr Opin Endocrinol Diabetes Obes 2014; 21:30-38
7. Eggermann T, Perez de Nanclares G, Maher ER, et al. Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci. Clin Epigenetics 2015; 7:123
8. Nordin M, Bergman D, Halje M, et al. Epigenetic regulation of the Igf2/H19 gene cluster. Cell Prolif 2014; 47:189-199
9. Binder G, Seidel A-K, Weber K, et al. IGF-II serum levels are normal in children with Silver-Russell syndrome who frequently carry epimutations at the IGF2 locus. J Clin Endocrinol Metab 2006; 91:4709-4712
10. Gicquel C, Rossignol S, Cabrol S, et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet 2005; 37:1003-1007
11. Wakeling EL. Silver-Russell syndrome. Arch Dis Child 2011; 96:1156-1161
12. Vals M-A, Yakoreva M, Kahre T, et al. The frequency of methylation abnormalities among Estonian patients selected by clinical diagnostic scoring systems for Silver-Russell syndrome and Beckwith-Wiedemann syndrome. Genet Test Mol Biomarkers 2015; 19:684-691
13. Eggermann T, Gonzalez D, Spengler S, et al. Broad clinical spectrum in Silver-Russell syndrome and consequences for genetic testing in growth retardation. Pediatrics 2009; 123:e929-e931
14. Dias RP, Nightingale P, Hardy C, et al. Comparison of the clinical scoring systems in Silver-Russell syndrome and development of modified diagnostic criteria to guide molecular genetic testing. J Med Genet 2013; 50:635-639
15. Binder G, Seidel A-K, Martin DD, et al. The endocrine phenotype in Silver-Russell syndrome is defined by the underlying epigenetic alteration. J Clin Endocrinol Metab 2008; 93:1402-1407
16. Netchine I, Rossignol S, Dufourg M-N, et al. 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations. J Clin Endocrinol Metab 2007; 92:3148-3154
17. Azzi S, Salem J, Thibaud N, et al. A prospective study validating a clinical scoring system and demonstrating phenotypical-genotypical correlations in Silver-Russell syndrome. J Med Genet 2015; 52:446-453
18. Wakeling EL, Amero SA, Alders M, et al. Epigenotype-phenotype correlations in Silver-Russell syndrome. J Med Genet 2010; 47:760-768
19. Bliek J, Terhal P, van den Bogaard M-J, et al. Hypomethylation of the H19 gene causes not only Silver-Russell syndrome (SRS) but also isolated asymmetry or an SRS-like phenotype. Am J Hum Genet 2006; 78:604-614
20. Fuke T, Mizuno S, Nagai T, et al. Molecular and clinical studies in 138 Japanese patients with Silver-Russell syndrome. PloS One 2013; 8:e60105
21. Kotzot D, Schmitt S, Bernasconi F, et al. Uniparental disomy 7 in Silver-Russell syndrome and primordial growth retardation. Hum Mol Genet 1995; 4:583-587
22. Begemann M, Spengler S, Gogiel M, et al. Clinical significance of copy number variations in the 11p15.5 imprinting control regions: new cases and review of the literature. J Med Genet 2012; 49:547-553
23. Gronskov K, Poole RL, Hahnemann JM, et al. Deletions and rearrangements of the H19/IGF2 enhancer region in patients with Silver-Russell syndrome and growth retardation. J Med Genet 2011; 48:308-311
24. Brioude F, Oliver-Petit I, Blaise A, et al. CDKN1C mutation affecting the PCNA-binding domain as a cause of familial Russell Silver syndrome. J Med Genet 2013; 50:823-830
25. Begemann M, Zirn B, Santen G, et al. Paternally inherited IGF2 mutation and growth restriction. N Engl J Med 2015; 373:349-356
26. Kagami M, Mizuno S, Matsubara K, et al. Epimutations of the IG-DMR and the MEG3-DMR at the 14q32.2 imprinted region in two patients with Silver-Russell Syndrome-compatible phenotype. Eur J Hum Genet 2015; 23:1062-1067
27. Ioannides Y, Lokulo-Sodipe K, Mackay DJ, et al. Temple syndrome: improving the recognition of an underdiagnosed chromosome 14 imprinting disorder: an analysis of 51 published cases. J Med Genet 2014; 51:495-501
28. Eggermann K, Bliek J, Brioude F, et al. EMQN best practice guidelines for genetic testing of chromosome 11p15 Imprinting Disorders: Silver-Russell and Beckwith-Wiedemann syndrome. Eur J Hum Genet 2016; (In press)
29. Marsaud C, Rossignol S, Tounian P, et al. Prevalence and management of gastrointestinal manifestations in Silver-Russell syndrome. Arch Dis Child 2015; 100:353-358
30. Wollmann HA, Kirchner T, Enders H, et al. Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur J Pediatr 1995; 154:958-968
31. Ezzahir N, Alberti C, Deghmoun S, et al. Time course of catch-up in adiposity influences adult anthropometry in individuals who were born small for gestational age. Pediatr Res 2005; 58:243-247
32. Azcona C, Stanhope R. Hypoglycaemia and Russell-Silver syndrome. J Pediatr Endocrinol Metab 2005; 18:663-670
33. Searle C, Johnson D. Russel-Silver syndrome: a historical note and comment on an older adult. Am J Med Genet A 2016; 170:466-470
34. Ranke MB, Lindberg A. Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell Syndrome treated with growth hormone: analysis of data from KIGS. Horm Res Paediatr 2010; 74:259-266
35. Smeets CCJ, Zandwijken GRJ, Renes JS, Hokken-Koelega ACS. Long-term results of GH treatment in Silver-Russell syndrome (SRS): do they benefit the same as non-SRS short-SGA? J Clin Endocrinol Metab 2016. [Epub ahead of print]. jc.2015-4273
36. Binder G, Liebl M, Woelfle J, et al. Adult height and epigenotype in children with Silver-Russell syndrome treated with GH. Horm Res Pædiatrics 2013; 80:193-200
37. Iliev DI, Kannenberg K, Weber K, Binder G. IGF-I sensitivity in Silver-Russell syndrome with IGF2/H19 hypomethylation. Growth Horm IGF Res 2014; 24:187-191
38. Myers SE, Whitman BY, Carrel AL, et al. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A 2007; 143A:443-448
39. Lem AJ, van der Kaay DC, de Ridder MA, et al. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial. J Clin Endocrinol Metab 2012; 97:4096-4105
40. van der Steen M, Lem AJ, van der Kaay DC, et al. Metabolic health in short children born small for gestational age treated with growth hormone and gonadotropin-releasing hormone analog: results of a randomized, dose-response trial. J Clin Endocrinol Metab 2015; 100:3725-3734
41. Augustine EF, Blackburn J, Pellegrino JE, et al. Myoclonus-dystonia syndrome associated with Russell Silver syndrome. Mov Disord 2013; 28:841-842
42. Kisnisci RS, Fowel SD, Epker BN. Distraction osteogenesis in Silver Russell syndrome to expand the mandible. Am J Orthod Dentofac Orthop 1999; 116:25-30
43. Eggermann T, Brioude F, Russo S, et al. Prenatal molecular testing for Beckwith-Wiedemann and Silver-Russell syndromes: a challenge for molecular analysis and genetic counseling. Eur J Hum Genet 2015. doi:10.1038/ejhg.2015.224